These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19820771)

  • 21. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.
    Ciuffetti G; Sokola E; Lombardini R; Pasqualini L; Pirro M; Mannarino E
    Kardiol Pol; 2003 Sep; 59(9):197-204. PubMed ID: 14618196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Iloprost and pentoxifylline on renal ischemia-reperfusion in rabbit model.
    Emrecan B; Tulukoglu E; Bozok S; Kestelli M; Onem G; Küpelioglu A; Yagdi S; Gürbüz A
    Eur J Med Res; 2006 Jul; 11(7):295-9. PubMed ID: 16899424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute coronary syndrome, stroke, arterial occlusive disease. Bring the patients out of the danger zone!].
    Füessl HS
    MMW Fortschr Med; 2004; 146 Suppl 1():3. PubMed ID: 15493407
    [No Abstract]   [Full Text] [Related]  

  • 24. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA; Pande RL; Hiatt WR
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombotic events in patients with systemic sclerosis treated with iloprost.
    Tedeschi A; Meroni PL; Del Papa N; Salmaso C; Boschetti C; Miadonna A
    Arthritis Rheum; 1998 Mar; 41(3):559-60. PubMed ID: 9506585
    [No Abstract]   [Full Text] [Related]  

  • 26. Stroke and atherothrombosis: an update on the role of antiplatelet therapy.
    Alexandrov AV; Alagona P
    Int J Stroke; 2008 Aug; 3(3):175-81. PubMed ID: 18705896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibition of platelet aggregation].
    Wascher T
    Wien Klin Wochenschr; 2012 Dec; 124 Suppl 2():31-2. PubMed ID: 23250462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-operative long-term optimization with prostanoids in initially inoperable severe chronic thromboembolic pulmonary hypertension (CTEPH): a step forward?
    Tsangaris H; Armaganidis A; Argentos S; Chamogeorgakis T; Rallidis L; Lekakis L; Orfanos SE
    J Heart Lung Transplant; 2007 Dec; 26(12):1346-7. PubMed ID: 18096491
    [No Abstract]   [Full Text] [Related]  

  • 29. Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.
    Jäger M; Tillmann FP; Thornhill TS; Mahmoudi M; Blondin D; Hetzel GR; Zilkens C; Krauspe R
    Arthritis Res Ther; 2008; 10(5):R120. PubMed ID: 18834533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multiple cholesterol emboli].
    Sidoti CP; Kehtari R; Enrico JF
    Rev Med Suisse Romande; 1996 Jun; 116(6):473-82. PubMed ID: 8711299
    [No Abstract]   [Full Text] [Related]  

  • 31. Cholesterol embolization to bladder in setting of transient ischemic attack and hematochezia: an unusual presentation of cholesterol embolization syndrome.
    Black CE; Cold CJ; Unwala DJ
    Urology; 2010 Oct; 76(4):791-3. PubMed ID: 20800883
    [No Abstract]   [Full Text] [Related]  

  • 32. [Modification of some prothrombotic indices after treatment with iloprost in arterial disease patients].
    Ferlito S; Bonomo T; Costa R; Di Salvo MM; Attanasio L; Finocchiaro PM; Condorelli M; Mazzone D
    Minerva Cardioangiol; 1996 Dec; 44(12):645-8. PubMed ID: 9053818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol crystal embolism: diagnosis and treatment.
    Meyrier A
    Kidney Int; 2006 Apr; 69(8):1308-12. PubMed ID: 16614719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cytoprotective effect of iloprost against carbon tetrachloride induced necrosis in rat liver.
    Bozkurt S; Ersoy E; Tekýn HE; Bayram O; Anadol Z; Onuk E; Ercan ZS
    Res Commun Mol Pathol Pharmacol; 1997 Mar; 95(3):343-6. PubMed ID: 9144840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Various therapy options. Medical Chemistry of platelet aggregation inhibitors].
    Zettl H; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2009; 38(4):314-9. PubMed ID: 19572349
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of prostacyclin and its analogues in the treatment of cardiovascular disease.
    Fink AN; Frishman WH; Azizad M; Agarwal Y
    Heart Dis; 1999; 1(1):29-40. PubMed ID: 11720602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iloprost in dermatology.
    Wohlrab J; Schanz S; Ulrich J
    J Dtsch Dermatol Ges; 2011 Jan; 9(1):56-63. PubMed ID: 21083647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iloprost and pentoxifylline attenuate ischemia-reperfusion injury in skeletal muscle in rabbit model.
    Emrecan B; Tulukoğlu E; Bozok S; Aksun M; Yağdi S; Ozcan AV; Saçar M; Gürbüz A
    Ulus Travma Acil Cerrahi Derg; 2008 Jul; 14(3):182-7. PubMed ID: 18781412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outpatient treatment of severe peripheral ischemia with intravenous intermittent low-dose iloprost. An open pilot study.
    Banyai S; Jenelten R; Wagner S; Allmann J; Banyai M; Koppensteiner R
    Int Angiol; 2002 Mar; 21(1):36-43. PubMed ID: 11941272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subacute renal failure in diabetic nephropathy due to endocapillary glomerulonephritis and cholesterol embolization.
    Rivera F; Vazmediano C; Gonzalez-Lopez L; Carrano A; Blanco J
    J Nephrol; 2008; 21(4):615-20. PubMed ID: 18651554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.